ASHLEY CRAWFORD: Open Payments
NPI 1487398558 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 36 payments from 9 companies in 2025. Trend: 2023 $25 · 2024 $382 · 2025 $858
Food & beverage: $858
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $240 |
| ABBVIE INC. | 8 | $207 |
| AstraZeneca Pharmaceuticals LP | 9 | $165 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Novo Nordisk Inc | 2 | $56 |
| PFIZER INC. | 3 | $49 |
| Gilead Sciences, Inc. | 1 | $30 |
| Astellas Pharma US Inc | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: AIRSUPRA, ZEPBOUND, MOUNJARO, QULIPTA, Kerendia, Ozempic, NURTEC ODT, CREON.
Industry payments across WI — which companies pay providers there.
